Geode Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-407,822
| Closed | -$1.65M | – | 4696 |
|
|
2023
Q4 | $1.65M | Buy |
407,822
+2,244
| +0.6% | +$9.09K | ﹤0.01% | 3171 |
|
|
2023
Q3 | $1.09M | Sell |
405,578
-15,944
| -4% | -$42.9K | ﹤0.01% | 3283 |
|
|
2023
Q2 | $3.93M | Buy |
421,522
+93,652
| +29% | +$874K | ﹤0.01% | 2822 |
|
|
2023
Q1 | $2.91M | Buy |
327,870
+28,264
| +9% | +$251K | ﹤0.01% | 2874 |
|
|
2022
Q4 | $1.49M | Buy |
299,606
+12,211
| +4% | +$60.8K | ﹤0.01% | 3178 |
|
|
2022
Q3 | $1.67M | Buy |
287,395
+31,256
| +12% | +$181K | ﹤0.01% | 3148 |
|
|
2022
Q2 | $1.42M | Buy |
256,139
+53,703
| +27% | +$297K | ﹤0.01% | 3260 |
|
|
2022
Q1 | $2.33M | Buy |
202,436
+10,389
| +5% | +$120K | ﹤0.01% | 3180 |
|
|
2021
Q4 | $2.44M | Buy |
+192,047
| New | +$2.44M | ﹤0.01% | 3279 |
|